This study will evaluate the safety and efficacy of AXS-05 in a randomized, double-blind, active-controlled study in patients diagnosed with major depressive disorder (MDD) experiencing an acute episode.
Randomized, Double-Blind, Active-Controlled Study of AXS-05 for MDD.